Browse > Article
http://dx.doi.org/10.5090/jcs.21.056

Non-conservative Management of Chylothorax  

Ahn, Hyo Yeong (Department of Thoracic and Cardiovascular Surgery, Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine)
I, Hoseok (Department of Thoracic and Cardiovascular Surgery, Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine)
Publication Information
Journal of Chest Surgery / v.54, no.4, 2021 , pp. 325-329 More about this Journal
Abstract
Chylothorax is caused by lymphatic leakage, which can develop after thoracic surgery and is associated with cancer. Although prospective randomized trials have not been performed, radiological interventions have been performed in several cases with persistent chylothorax, adjunct to 2 weeks of conservative management. The success rate of such interventions is diverse due to anatomical variations, although the results are promising. However, in cases of treatment failure after cycles of interventions, a team approach may be necessary to determine whether surgical management is warranted.
Keywords
Chylothorax; Management; Intervention; Surgery;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Liu Z, Du M, Liang Y, Ju S, Li X, Gao Y. Prophylactic ligation of the thoracic duct branch prevents chylothorax after pulmonary resection for right lung cancer. Surg Today 2020;50:881-8.   DOI
2 Hara H, Mihara M, Yamamoto M. Therapeutic lymphangiography for traumatic chylothorax. J Vasc Surg Venous Lymphat Disord 2018; 6:237-40.   DOI
3 Schild HH, Strassburg CP, Welz A, Kalff J. Treatment options in patients with chylothorax. Dtsch Arztebl Int 2013;110:819-26.
4 Schild HH, Pieper C. Chylothorax: current therapeutic options. Zentralbl Chir 2019;144:S24-30.   DOI
5 Tenny BC, Madjarov J, Shipe T. Surgical intervention in a complicated persistent chyle leak. Int J Surg Case Rep 2018;42:7-9.   DOI
6 Matsumoto T, Yamagami T, Kato T, et al. The effectiveness of lymphangiography as a treatment method for various chyle leakages. Br J Radiol 2009;82:286-90.   DOI
7 Jeon YJ, Cho JH, Hyun D, et al. Management of chyle leakage after general thoracic surgery: impact of thoracic duct embolization. Thorac Cancer 2021;12:1382-6.   DOI
8 Takuwa T, Yoshida J, Ono S, et al. Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer. J Thorac Cardiovasc Surg 2013;146:571-4.   DOI
9 Sharkey AJ, Rao JN. The successful use of octreotide in the treatment of traumatic chylothorax. Tex Heart Inst J 2012;39:428-30.
10 Binkert CA, Yucel EK, Davison BD, Sugarbaker DJ, Baum RA. Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique. J Vasc Interv Radiol 2005;16:1257-62.   DOI
11 Borcyk K, Kamil A, Hagerty K, Deer M, Tomich P, Anderson Berry AL. Successful management of extremely high-output refractory congenital chylothorax with chemical pleurodesis using 4% povidone-iodine and propranolol: a case report. Clin Case Rep 2018;6: 702-8.   DOI
12 Juszczyk K, Waugh R, Sandroussi C. Lymphangiography as therapeutic management of chylothorax. J Med Imaging Radiat Oncol 2013;57:460-1.   DOI
13 Tapias LF, Morse CR. A preliminary experience with minimally invasive Ivor Lewis esophagectomy. Dis Esophagus 2012;25:449-55.   DOI
14 Lutz P, Strunk H, Schild HH, Sauerbruch T. Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis. World J Gastroenterol 2013;19:1140-2.   DOI
15 Arshava EV, Parekh KR. Thoracoscopic thoracic duct ligation: how I teach it. Ann Thorac Surg 2020;109:1330-4.   DOI
16 Yang RF, Liu TT, Wang P, et al. Ligation of thoracic duct during thoracoscopic esophagectomy can lead to decrease of T lymphocyte. J Cancer Res Ther 2018;14:1535-9.   DOI
17 Yamagami T, Masunami T, Kato T, et al. Spontaneous healing of chyle leakage after lymphangiography. Br J Radiol 2005;78:854-7.   DOI
18 Nadolski GJ, Itkin M. Lymphangiography and thoracic duct embolization following unsuccessful thoracic duct ligation: imaging findings and outcomes. J Thorac Cardiovasc Surg 2018;156:838-43.   DOI
19 Sommer CM, Pieper CC, Itkin M, et al. Conventional lymphangiography (CL) in the management of postoperative lymphatic leakage (PLL): a systematic review. Rofo 2020;192:1025-35.   DOI
20 Jayasinghe SA, Srinivasa RN, Hage AN, Gemmete JJ, Majdalany BS, Chick JF. Thoracic duct embolization: analysis of practice patterns. Ann Vasc Surg 2018;52:168-75.   DOI
21 Kim PH, Tsauo J, Shin JH. Lymphatic interventions for chylothorax: a systematic review and meta-analysis. J Vasc Interv Radiol 2018;29: 194-202.   DOI
22 Yamagata Y, Saito K, Hirano K, Oya M. Laparoscopic transhiatal thoracic duct ligation for chylothorax after esophagectomy. Thorac Cardiovasc Surg 2019;67:606-9.   DOI
23 Jun H, Hur S. Interventional radiology treatment for postoperative chylothorax. Korean J Thorac Cardiovasc Surg 2020;53:200-4.   DOI
24 Varshney VK, Suman S, Garg PK, Soni SC, Khera PS. Management options for post-esophagectomy chylothorax. Surg Today 2021;51: 678-85.   DOI
25 Bazancir LA, Jensen RJ, Frevert SC, Ryom P, Achiam MP. Embolization of the thoracic duct in patients with iatrogenic chylothorax. Dis Esophagus 2021 Feb 8 [Epub]. https://doi.org/10.1093/dote/ doab001.   DOI
26 Pulle MV, Puri HV, Asaf BB, Bishnoi S, Yadav A, Kumar A. Chylothorax: modalities of management and outcomes: a case series. Lung India 2021;38:154-60.   DOI